Leading science, pioneering therapies

CRM Publications

Found 36 results
Filters: Keyword is Brain  [Clear All Filters]
2015
Illingworth R, Gruenewald-Schneider U, De Sousa D, Webb S, Merusi C, Kerr ARW, James KD, Smith C, Walker R, Andrews R et al..  2015.  Inter-individual variability contrasts with regional homogeneity in the human brain DNA methylome.Nucleic Acids Res. 43(2):732-44.
2014
Jaarsma D, van den Berg R, Wulf PS, van Erp S, Keijzer N, Schlager MA, de Graaff E, De Zeeuw CI, R Pasterkamp J, Akhmanova A et al..  2014.  A role for Bicaudal-D2 in radial cerebellar granule cell migration.Nat Commun. 5:3411.
2013
Reimer MM, Norris A, Ohnmacht J, Patani R, Zhong Z, Dias TB, Kuscha V, Scott AL, Chen Y-C, Rozov S et al..  2013.  Dopamine from the brain promotes spinal motor neuron generation during development and adult regeneration.Dev Cell. 25(5):478-91.
Stoffels JMJ, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Sisková Z, Maier O, ffrench-Constant C, Franklin RJM et al..  2013.  Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.Brain. 136(Pt 1):116-31.
2011
Sprooten E, Sussmann JE, Moorhead TW, Whalley HC, ffrench-Constant C, Blumberg HP, Bastin ME, Hall J, Lawrie SM, McIntosh AM.  2011.  Association of white matter integrity with genetic variation in an exonic DISC1 SNP.Mol Psychiatry. 16(7):685,688-9.
Stankoff B, Freeman L, Aigrot M-S, Chardain A, Dollé F, Williams AC, Galanaud D, Armand L, Lehericy S, Lubetzki C et al..  2011.  Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.Ann Neurol. 69(4):673-80.
2010
Anderson JMarian, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MGrazia, Chandran S.  2010.  Abnormal tau phosphorylation in primary progressive multiple sclerosis.Acta Neuropathol. 119(5):591-600.
Schaefer A, Im H-I, Venø MT, Fowler CD, Min A, Intrator A, Kjems J, Kenny PJ, O'Carroll D, Greengard P.  2010.  Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction.J Exp Med. 207(9):1843-51.
Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, Webb S, Kerr ARW, Deaton A, Andrews R, James KD et al..  2010.  CpG islands influence chromatin structure via the CpG-binding protein Cfp1.Nature. 464(7291):1082-6.
Iovino M, Patani R, Watts C, Chandran S, Spillantini MGrazia.  2010.  Human stem cell-derived neurons: a system to study human tau function and dysfunction.PLoS One. 5(11):e13947.
Skene PJ, Illingworth R, Webb S, Kerr ARW, James KD, Turner DJ, Andrews R, Bird AP.  2010.  Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state.Mol Cell. 37(4):457-68.
Kazanis I, Lathia JD, Vadakkan TJ, Raborn E, Wan R, Mughal MR, D Eckley M, Sasaki T, Patton B, Mattson MP et al..  2010.  Quiescence and activation of stem and precursor cell populations in the subependymal zone of the mammalian brain are associated with distinct cellular and extracellular matrix signals.J Neurosci. 30(29):9771-81.
2009
Anderson JMarian, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MGrazia, Chandran S.  2009.  Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis.Acta Neuropathol. 117(5):583-9.
Czopka T, Von Holst A, Schmidt G, ffrench-Constant C, Faissner A.  2009.  Tenascin C and tenascin R similarly prevent the formation of myelin membranes in a RhoA-dependent manner, but antagonistically regulate the expression of myelin basic protein via a separate pathway.Glia. 57(16):1790-801.
2008
Anderson JM, Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds R, ffrench-Constant C, Giovannoni G, Compston DAS, Baker D et al..  2008.  Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis.Brain. 131(Pt 7):1736-48.
2005
Caballero IMartín, Hendrich B.  2005.  MeCP2 in neurons: closing in on the causes of Rett syndrome.Hum Mol Genet. 14 Spec No 1:R19-26.
Ramos-Mejía V, Escalante-Alcalde D, Kunath T, Ramírez L, Gertsenstein M, Nagy A, Lomelí H.  2005.  Phenotypic analyses of mouse embryos with ubiquitous expression of Oct4: effects on mid-hindbrain patterning and gene expression.Dev Dyn. 232(1):180-90.
2002
Ying Q-L, Nichols J, Evans EP, Smith AG.  2002.  Changing potency by spontaneous fusion.Nature. 416(6880):545-8.
Suárez I, Bodega G, Fernández B.  2002.  Glutamine synthetase in brain: effect of ammonia.Neurochem Int. 41(2-3):123-42.
Zarei M, Collins VP, Chandran S, Valler D, Higgins JNP, Compston DAS, Yates JRW.  2002.  Tuberous sclerosis presenting in late adult life.J Neurol Neurosurg Psychiatry. 73(4):436-8.
2001
Hendrich B, Guy J, Ramsahoye B, Wilson V, Bird A.  2001.  Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development.Genes Dev. 15(6):710-23.
Rose K, Allan A, Gauldie S, Stapleton G, Dobbie L, Dott K, Martin C, Wang L, Hedlund E, Seckl JR et al..  2001.  Neurosteroid hydroxylase CYP7B: vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation.J Biol Chem. 276(26):23937-44.
Bean R, Seckl JR, Lathe R, Martin C.  2001.  Ontogeny of the neurosteroid enzyme Cyp7b in the mouse.Mol Cell Endocrinol. 174(1-2):137-44.
2000
Pratt T, Sharp L, Nichols J, Price DJ, Mason JO.  2000.  Embryonic stem cells and transgenic mice ubiquitously expressing a tau-tagged green fluorescent protein.Dev Biol. 228(1):19-28.

Pages